• Deferasirox, Lysosomal Stress, and Translational Leverage

  2026-08-20

  Deferasirox is more than an oral iron chelator for iron overload: it is a mechanistic probe for studying how iron availability, mitochondrial ROS, myeloid differentiation, and lysosomal stress intersect. This article connects the TCF25–V-ATPase–ferritinophagy axis to translational iron-chelation research while defining the experiments needed to distinguish hypothesis from evidence.

• Rotigotine hydrochloride Assay Guide

  2026-08-20

  A scenario-driven guide to using Rotigotine hydrochloride (SKU A3777) in cell viability, proliferation, cytotoxicity, and dopaminergic signaling workflows. It connects concentration selection, receptor interpretation, solution preparation, translational evidence, and vendor evaluation to practical laboratory decisions.

• Plerixafor (AMD3100) Experimental Workflow Guide

  2026-08-19

  Plerixafor (AMD3100) provides a practical way to interrogate CXCL12/CXCR4 signaling across cancer migration, stem-cell trafficking, and immune-cell redistribution. This workflow-focused guide covers assay design, benchmark comparisons, formulation, and troubleshooting for more reproducible results.

• Platelet Extravasation in Tumors: CXCR4 Control

  2026-08-19

  The reference study establishes that platelet entry into tumors is an actively regulated form of transendothelial migration rather than a passive consequence of vascular damage. It identifies stromal CXCL12–CXCR4 signaling, platelet FAK and PECAM-1, and distinct granule-release pathways as separable control points linking platelet trafficking with tumor growth.

• Drosophila Keap1 Nuclear Condensates Under Oxidative Stress

  2026-08-18

  This study identifies a stress-responsive nuclear condensate function for Drosophila Keap1 (dKeap1), linking its subcellular behavior to domain architecture and intrinsically disordered regions. Fluorescence imaging, FRAP, domain deletions, and in vitro reconstitution show that the dKeap1 C-terminal region promotes condensate formation, whereas the Kelch domain restrains it.

• Caspase-3 Colorimetric Assay Kit: Practical Guide

  2026-08-18

  The Caspase-3 Colorimetric Assay Kit provides a plate- or spectrophotometer-based method for measuring DEVD-dependent caspase-3 activity in biological samples and comparing activity with controls. It is intended for biochemical apoptosis research, including Alzheimer's disease research, but should not be used as an in vivo or clinical diagnostic readout.

• hiPSC Intestinal Organoids for Pharmacokinetic Studies

  2026-08-17

  Saito and colleagues established a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids can be cryopreserved, propagated, and differentiated into epithelial cells with transporter and CYP3A activity, providing a more human-relevant platform for intestinal absorption and drug-metabolism research.

• Zolmitriptan: A Mechanistic Guide for Assays

  2026-08-17

  Zolmitriptan is a selective 5-HT1B receptor agonist for investigating migraine and trigeminal signaling. This guide connects receptor-proximal assay design with lessons from lysosome-focused antiviral research while clearly separating established pharmacology from exploratory cross-domain questions.

• KU-55933: Selective ATM Kinase Inhibitor

  2026-08-16

  KU-55933 is a potent and selective ATM kinase inhibitor for DNA damage response research and cell-based pathway studies. Product information reports a 13 nM IC50, a 2.2 nM Ki, inhibition of ATM-mediated Akt phosphorylation, and research-use-only status.

• AZD8055: Practical mTOR Inhibitor Workflow

  2026-08-15

  AZD8055 is a selective ATP-competitive mTOR inhibitor for experimentally separating mTORC1 and mTORC2 pathway effects in cellular and animal models. It is appropriate for preclinical mechanism and pharmacodynamic studies, but its water insolubility, limited clinical benefit in phase I testing, and lack of paper-matched evidence make it unsuitable as a stand-alone basis for clinical efficacy claims.

• ML365: From Channel Blockade to Causal Biology

  2026-08-14

  ML365 is a selective TASK1 potassium channel inhibitor that connects membrane excitability with inflammatory biology. This evidence-focused guide explains how to use cross-platform potency, orthogonal endpoints, and careful controls for stronger ion channel pharmacology research.

• MK 0893: From Allostery to Assay Design

  2026-08-14

  MK 0893 is a glucagon receptor antagonist that connects nanomolar receptor pharmacology with interpretable cellular and in vivo diabetes assays. This article explains how its allosteric mechanism, endpoint-specific potency, and translational limitations should shape experimental design.

• Azithromycin and Roxithromycin as Senolytics

  2026-08-13

  Ozsvari and colleagues developed a fibroblast-based senolytic screening strategy and identified azithromycin and roxithromycin as selective eliminators of DNA-damage-induced senescent human fibroblasts. Their results support drug repurposing while showing that senolytic activity is not shared uniformly across closely related macrolide antibiotics and may involve metabolic and autophagic changes.

• Magneto-Piezoelectric Scaffolds for Infected Bone Repair

  2026-08-13

  Wu and colleagues developed a dual-responsive scaffold that combines magnetic biofilm disruption with ultrasound-mediated activation of Icam1+ macrophage oxidative phosphorylation. The study links scaffold-induced JAK2-STAT3 activation and MAPK-JNK suppression to improved immune regulation and healing of infectious bone defects.

• WP1066 JAK2/STAT3 Inhibitor Guide

  2026-08-12

  WP1066 is a cell-permeable JAK2/STAT3 inhibitor for mechanistic cancer research. Product data describe pathway inhibition, apoptosis, Caki-1 xenograft activity, and AML cell-model activity, while the cited macrophage study supports a separate context in which JAK2-STAT3 activation promotes bone repair.

15442 records 1/1030 page Next 12345 下5页 Last page